DNA Vaccines Market: By Type (Animal DNA vaccine and Human DNA vaccine), By Application (Human disease and Veterinary disease), By Technology (Plasmid DNA vaccines and Plasmid DNA delivery) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

DNA Vaccines Market size is valued at USD 453.4 million in 2022 and is poised to grow at a CAGR of 6.6% from 2023 - 2029. DNA vaccination is a method for shielding an individual against illness by vaccinating it with genetically engineered DNA, so cells directly manufacture an antigen, ensuing in a defensive immunological response. It contains delivering genes or fragments of it, training immunogenic antigens to the cells of the host by utilizing DNA plasmids as a vector. This method encourages both cell-mediated and humoral immune responses efficiently. DNA vaccines are third-generation vaccines precisely designed to overcome the unsolicited possessions of conventional vaccines. The surge in the vulnerability of the population to communicable diseases and the growth in a number of antibiotic-resistant pathogens have created the necessity for low-cost and effective vaccination, which would deliver immunity for a longer time period. The global market provides a detailed overview of the DNA Vaccines market size, and that can be segmented by type, by application, and by technology. By type, the DNA Vaccines market growth has been segmented into Animal DNA vaccine and Human DNA vaccine. The animal DNA vaccine segment is likely to be the significant growing segment in terms of type. Based on Application, the DNA Vaccines market is segmented into Human application and Veterinary applications. Among these, the Human application segment is expected to have a significant growing market during the forecast period 2022-2028. Based on the technology, the DNA Vaccines market is segmented Plasmid DNA vaccines and Plasmid DNA delivery. The Plasmid DNA Preparation delivery segment is expected to have a significant share in 2021.

DNA Vaccines Market Key Developments:

  • In August 2021, the three-dose ZyCoV-D vaccine  protected against symptomatic disease in 66% of those vaccinated

Dna Vaccines Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.6%

Largest Market

North-America

Fastest Growing Market

Europe
DNA Vaccines Market Dynamics

The increase in the prevalence of infectious and cancer diseases in humans and animals increase in the need for DNA vaccines due to their advantages are anticipated to propel the market growth over the forecast years. Moreover, the surge in number of antibiotics resistant pathogens is burgeoning the market growth over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Dna Vaccines Market Segmentation

By Type
  • Animal DNA vaccine
  • Human DNA vaccine
By Technology
  • Plasmid DNA vaccines
  • Plasmid DNA delivery
By Application
  • Human disease
  • Veterinary disease

Frequently Asked Questions

growth of new vaccines using DNA technology, and high potential for growth in unexploited developing economies.

lack of immunogenicity related with DNA vaccines

On February 2022, Alvea launched a shelf-stable DNA vaccine against the new SARS- CoV-2.

Easy DNA vaccine product approval and presence of key players in these regions

Table of Content

  1. Executive Summary
  2. Global DNA Vaccines Market Introduction
    • Global DNA Vaccines Market - Taxonomy
    • Global DNA Vaccines Market -Definitions
      • Type
      • Application
      • Technology
  1. Global DNA Vaccines Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global DNA Vaccines Market Dynamic Factors - Impact Analysis
    • Global DNA Vaccines Market - Competition Landscape
  2. Global DNA Vaccines Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029(Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global DNA Vaccines Market, By Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Animal DNA vaccine
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Human DNA vaccine
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global DNA Vaccines Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Human disease
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Veterinary disease
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global DNA Vaccines Market, By Technology, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Plasmid DNA vaccines
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Plasmid DNA delivery
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global DNA Vaccines Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018 - 2022and Forecast, 2023 - 2029(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022and Forecast, 2023 - 2029(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022and Forecast, 2023 - 2029(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022and Forecast, 2023 - 2029(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022and Forecast, 2023 - 2029(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global DNA Vaccines Market - Opportunity Analysis Index, By Type, Application, Technology and Region, 2023 - 2029
  2. North America DNA Vaccines Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Type Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Animal DNA vaccine
      • Human DNA vaccine
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Human disease
      • Veterinary disease
    • Technology Analysis 2018 - 2022and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Plasmid DNA vaccines
      • Plasmid DNA delivery
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America DNA Vaccines Market - Opportunity Analysis Index, By Type, Application, Technology and Country, 2023 - 2029
    • North America DNA Vaccines Market Dynamics - Trends
  3. Europe DNA Vaccines Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Type Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Animal DNA vaccine
      • Human DNA vaccine
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Human disease
      • Veterinary disease
    • Technology Analysis 2018 - 2022and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Plasmid DNA vaccines
      • Plasmid DNA delivery
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • United Kingdom
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Europe DNA Vaccines Market - Opportunity Analysis Index, By Type, Application, Technology and Country, 2023 - 2029
    • Europe DNA Vaccines Market Dynamics - Trends
  4. Asia-Pacific DNA Vaccines Market Analysis, 2018 - 2022and Forecast, 2023 - 2029(Revenue, USD Mn)
    • Type Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Animal DNA vaccine
      • Human DNA vaccine
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Human disease
      • Veterinary disease
    • Technology Analysis 2018 - 2022and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Plasmid DNA vaccines
      • Plasmid DNA delivery
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • China
      • Japan
      • India
      • Australia & New Zealand
      • Rest of APAC
    • Asia-Pacific DNA Vaccines Market - Opportunity Analysis Index, By Type, Application, Technology and Country,2023 - 2029
    • Asia-Pacific DNA Vaccines Market Dynamics - Trends
  5. Latin America DNA Vaccines Market Analysis, 2018 - 2022and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Type Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Animal DNA vaccine
      • Human DNA vaccine
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Human disease
      • Veterinary disease
    • Technology Analysis 2018 - 2022and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Plasmid DNA vaccines
      • Plasmid DNA delivery
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Argentina
      • Mexico
      • Rest of LATAM
    • Latin America DNA Vaccines Market - Opportunity Analysis Index, By Type, Application, Technology and Country, 2023 - 2029
    • Latin America DNA Vaccines Market Dynamics - Trends
  6. Middle East and Africa DNA Vaccines Market Analysis, 2018 - 2022and Forecast, 2023 - 2029(Revenue, USD Mn)
    • Type Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Animal DNA vaccine
      • Human DNA vaccine
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Human disease
      • Veterinary disease
    • Technology Analysis 2018 - 2022and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Plasmid DNA vaccines
      • Plasmid DNA delivery
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • South Africa
      • Turkey
      • GCC Countries
      • Rest of MEA
    • MEA DNA Vaccines Market - Opportunity Analysis Index, By Application, Technology, Application, Deployment Type, and Country, 2023 - 2029
    • MEA DNA Vaccines Market Dynamics - Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Merck
      • GSK
      • Sanofi
      • Zoties
      • Elanco
      • Boehringer-Ingelheim
      • Indian Immunologicals
      • Plumbline Life Sciences
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • Merck & Co., Inc. (U.S.),
  • Sanofi Pasteur SA (France),
  • Astellas Pharma Inc. (Japan)
  • GlaxoSmithKline, plc (U.K.),
  • Pfizer, Inc. (U.S)
  • CSL Limited (Australia),
  • Emergent BioSolutions, Inc. (U.S.),
  • Panacea Biotec (India)
  • Protein Sciences Corporation (U.S)
  • Bavarian Nordic (Denmark)

Adjacent Markets